Back to Search
Start Over
Oral RevlimidRPlus Melphalan and Prednisone (R-MP) for Newly Diagnosed Multiple Myeloma.
- Source :
- Blood; November 2005, Vol. 106 Issue: 11 p785-785, 1p
- Publication Year :
- 2005
-
Abstract
- Introduction.Lenalidomide (RevlimidR) is a novel, orally active immunomodulatory drug effective for the treatment of refractory myeloma. In this multicenter trial, we evaluate the potential additive and synergistic effect of the combination RevlimidR, melphalan and prednisone (R-MP).
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 106
- Issue :
- 11
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56858667
- Full Text :
- https://doi.org/10.1182/blood.V106.11.785.785